Similarly, treatment of CRC and MCC patients whose tumors show epigenetic silencing of ATOH1 with DNA methyltransferase inhibitors might prove a powerful avenue for therapy, because it appears to be sufficient to restore ATOH1 expression and induce cancer cell death. Here, ATOH1 is linked to Merkel cell skin cancer.